Given the recent uptick in COVID-19 cases in the US, many InCrowd panelists have been reporting that they do not expect things to return to normal until a vaccine is developed and disseminated. In order to deepen our understanding of the COVID-19 vaccine landscape, we surveyed infectious disease specialists across the country to get their perception and predictions on the efficacy, impact, and competitive landscape of COVID-19 vaccines.*
* Please note, views in this survey reflect opinions only as reported by responding physicians.
Methodology:
- Method:
- 12-Minute MicroSurvey via InCrowd
- Crowds:
- Infectious disease doctors
- Sample Size:
- n = 100
- Community Hospital, Academic Hospital, Office-based
- n = 100
- Fielding Period:
- October 22nd – 26th
InCrowd’s other COVID-19 Tracking Reports:
